Redhill Biopharma (RDHL) PT Raised to $28 at Nomura/Instinet
Tweet Send to a Friend
Nomura/Instinet raised its price target on Redhill Biopharma (NASDAQ: RDHL) to $28.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
